APA

Ercan D., Zejnullahu K., Yonesaka K., Xiao Y., Capelletti M., Rogers A., Lifshits E., Brown A., Lee C., Christensen J. G., Kwiatkowski D. J., Engelman J. A. & Jänne P. A. (20100504). Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor. : Oncogene.

Chicago

Ercan D, Zejnullahu K, Yonesaka K, Xiao Y, Capelletti M, Rogers A, Lifshits E, Brown A, Lee C, Christensen J G, Kwiatkowski D J, Engelman J A and Jänne P A. 20100504. Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor. : Oncogene.

Harvard

Ercan D., Zejnullahu K., Yonesaka K., Xiao Y., Capelletti M., Rogers A., Lifshits E., Brown A., Lee C., Christensen J. G., Kwiatkowski D. J., Engelman J. A. and Jänne P. A. (20100504). Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor. : Oncogene.

MLA

Ercan D, Zejnullahu K, Yonesaka K, Xiao Y, Capelletti M, Rogers A, Lifshits E, Brown A, Lee C, Christensen J G, Kwiatkowski D J, Engelman J A and Jänne P A. Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor. : Oncogene. 20100504.